HK

 

Beijing-based DOCVIT Law Firm has expanded its footprint by opening a new office in Hong Kong, the firm's tenth branch overall, amid a growing influx of mainland Chinese legal practices in the city.

The new office will engage in a variety of practice areas such as cross-border litigation and enforcement, family trusts, restructuring, mergers and acquisitions, bond funds, and overseas listings, reflecting the firm's broad legal expertise.

This move comes as Hong Kong's legal sector continues to attract mainland law firms, with the Law Society of Hong Kong reporting that 14 such firms have now secured local licenses, and an additional 29 operate as registered foreign law firms.

DOCVIT's latest expansion is strategically positioned to enhance its service network in the Guangdong-Hong Kong-Macao Greater Bay Area (GBA), supporting its aim to bolster its international service system, the firm said in a statement.

The firm, which also has offices in major Chinese cities including Shenzhen, Shanghai, and Wuhan, views its new Hong Kong branch as a key step in its ongoing growth and international outreach, it added.

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

Appointments

Dentons expands HK disputes team with NRF trio

by Asian Legal Business《亚洲法律杂志》 |

Global law firm Dentons has strengthened its litigation and arbitration practice in Hong Kong after hiring three lawyers from Norton Rose Fulbright, namely partner Alfred Wu, senior consultant Philip Nunn, and senior associate Muriel Cheng.

Appointments

SG: Former K&L Gates Straits Law head sets up own boutique

by Nimitt Dixit |

Veteran litigator Sreenivasan Narayan SC has left the managing partner role at K&L Gates Straits Law to set up his own dispute resolution and advisory firm in Singapore, Sreenivasan Chambers.

Features

EXPLAINER: Does Covishield’s alleged health concerns expose it to legal liability?

by Nimitt Dixit |

COVID-19 vaccine-maker AstraZeneca was in the spotlight in May following the company’s admission in a UK court proceeding of the possibility of a rare side effect, Thrombosis with Thrombocytopenia Syndrome (TTS) associated with its vaccines. More than 50 individuals have alleged the vaccine resulted in death and serious injuries from TTS.